
Naveen Pemmaraju/mdanderson.org
Jun 11, 2025, 13:51
Naveen Pemmaraju Shared 2025 Leukemia Review on Epigenetic Therapies in Myeloid Cancers
Naveen Pemmaraju, Professor at the Department of Leukemia of MD Anderson Cancer Center, shared a post on X:
“The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms.”
Title: The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms
Journal: Leukemia
Authors: Michael W. M. Kühn, Naveen Pemmaraju , Florian H. Heidel
More posts featuring Naveen Pemmaraju on OncoDaily
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 11, 2025, 13:48
Jun 11, 2025, 13:02